Evaluation of the long-term efficacy and safety of an imidacloprid 10%/flumethrin 4.5% polymer matrix collar (Seresto®) in dogs and cats naturally infested with fleas and/or ticks in multicentre clinical field studies in Europe

Particle and Fibre Toxicology

Klemens Krieger³  Klaus Hellmann¹  Christophe Le Sueur²  Eva Kruedewagen³  Isabel Radeloff¹  Julia Rass¹  Dorothee Stanneck³ 

[1] KLIFOVET AG, Munich, Germany;Bayer Santé S.A.S, Puteaux, France;Bayer Animal Health GmbH (BAH), Monheim, Germany

关键词: Field;    Collar;    Flumethrin;    Imidacloprid;    Safety;    Efficacy;    Ticks;    Fleas;    Ixodes ricinus;    Ixodes hexagonus;    Dermacentor reticulatus;    Pulex irritans;    Archaeopsylla erinacei;    Ctenocephalides canis;    Ctenocephalides felis;   

Others  :  1233010
DOI  :  10.1186/1756-3305-5-66

 received in 2012-01-17, accepted in 2012-03-31,  发布年份 2012

【 摘 要 】

Background

The objective of these two GCP multicentre European clinical field studies was to evaluate the long-term efficacy and safety of a new imidacloprid/flumethrin collar (Seresto^®, Bayer AnimalHealth, Investigational Veterinary Product(IVP)) in dogs and cats naturally infested with fleas and/or ticks in comparison to a dimpylat collar ("Ungezieferband fuer Hunde/fuer Katzen", Beaphar, Control Product (CP)).

Methods

232 (IVP) and 81 (CP) cats and 271(IVP) and 129 (CP) dogs were treated with either product according to label claims and formed the safety population. Flea and tick counts were conducted in monthly intervals for up to 8 months in the efficacy subpopulation consisting of 118 (IVP) + 47 (CP) cats and 197 (IVP) + 94 (CP) dogs. Efficacy was calculated as reduction of infestation rate within the same treatment group and statistically compared between the two treatment groups.

Results

Preventive efficacy against fleas in cats/dogs varied in the IVP group between 97.4%/94.1% and 100%/100% (overall mean: 98.3%/96.7%) throughout the 8 month period and in the CP group between 57.1%/28.2% and 96.1%/67.8% (overall mean: 79.3%/57.9%). Preventive efficacy against ticks in cats/dogs varied in the IVP group between 94.0%/91.2% and 100%/100% (overall mean: 98.4%/94.7%) throughout the 8 month period and in the CP group between 90.7%/79.9% and 100%/88.0% (overall mean: 96.9%/85.6%). The IVP group was statistically non-inferior to the CP group, and on various assessment days, statistical superiority was proven for flea and tick count reduction in dogs and cats. Both treatments proved to be safe in dogs and cats with mainly minor local observations at the application site. There was moreover, no incidence of any mechanical problem with the collar in dogs and cats during the entire study period.

Conclusions

The imidacloprid/flumethrin collar proved to reduce tick counts by at least 90% and flea counts by at least 95% for a period of at least 7-8 months in cats and dogs under field conditions. Therefore, it can be used as sustainable long-term preventative, covering the whole flea and tick season.

【 授权许可】

   
2012 Stanneck et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Steuber S, Bode K: Kriterien für die Zulassung von Tierarzneimitteln gegen Zeckenbefall bei Hunden und Katzen: Ein Überblick der aktuellen Anforderungen und Möglichkeiten unter Berücksichtigung der derzeitig gültigen Leitlinien. J Verbr Lebensm 2008, 3:195-200.
• [2]Pfister K: Arthropodenbefall bei Hund und Katze. In Veterinaermedizinische Parasitologie. Edited by Thomas Schnieder. Parey: Stuttgart; 2006:521-559.
• [3]Chomel B: Tick-borne infections in dogs - an emerging infectious threat. Vet Parasitol 2011, 179(4):294-301.
• [4]Baggott D, Ollagnier C, Yoon S, Collidor N, Mallouk Y, Cramer L: Efficacy of a novel combination of fipronil, amitraz and (S)-methoprene for treatment and control of tick species infesting dogs in Europe. Vet Parasitol 2011, 179(4):330-334.
• [5]Bouhsira E, Yoon S, Roques M, Manavella C, Vermont S, Cramer L, Ollagnier C, Franc M: Efficay of fipronil, amitraz and (S)-methoprene combination spot on for dogs against adult dog fleas (Ctenocephalides canis, Curtis, 1826). Vet Parasitol 2011, 179(4):351-353.
• [6]Liebisch A, Schein E, Dorn H, Liebisch G: Prevention of infestation with ticks and fleas with the dog collar KILTIX. Prakt Tierarzt 1996, 77(6):493-510.
• [7]Fourie LJ, Stanneck D, Horak IG: The efficacy of collars impregnated with flumethrin and propoxur against experimental infestations of adult Rhipicephalus sanguines on dogs. J S Afr Vet Assoc 2003, 74(4):123-126.
• [8]Mehlhorn H, Mencke N, Hansen O: Effects of imidacloprid on adult and larval stages of the flea Ctenocephalides felis after in vivo and in vitro application: a light- and electron-microscopy study. Parasitol Res 1999, 85(8-9):625-637.
• [9]Stanneck D, Ebbinghaus-Kintscher U, Schoenhense E, Kruedewagen EM, Turberg A, Leisewitz A, Jiritschka W, Krieger KJ: The synergistic action and release kinetics of 10% imidacloprid and 4.5% flumethrin in collars applied for ectoparasite control in dogs and cats. Parasit Vectors 2012, in press.
• [10]Stanneck D, Kruedewagen EM, Fourie JJ, Horak I, Davis W, Krieger KJ: The efficacy of an imidacloprid/flumethrin collar against fleas and ticks on cats. Parasit Vectors, in press.
• [11]Stanneck D, Kruedewagen EM, Fourie JJ, Horak I, Davis W, Krieger KJ: The efficacy of an imidacloprid/flumethrin collar against fleas, ticks, mites and lice on dogs. Parasit Vectors, in press.
• [12]Veterinary Medicines Directorate: Summary of Product Characteristics for Seresto/Foresto. [http:/ / www.vmd.defra.gov.uk/ ProductInformationDatabase/ SPC_Documents/ SPC_332767.doc] webcite
• [13]Linnett P: Permethrin toxicosis in cats. Aus Vet J 2008, 86:32-35.
• [14]Meyer EK: Toxicosis in cats erroneously treated with 45 to 65% permethrin products. J Am Vet Med Assoc 1999, 5:198-203.
• [15]Reid FM, Oeheme FW: Toxicoses. In The Cat: Diseases and Clinical Management. Edited by Sherding RG. New York: Churchill Livingstone; 1989:190.
• [16]Richardson JA: Permethrin spot-on toxicosis in cats. J Vet Emerg Crit Care 2000, 10:103-6.
• [17]Kaneko H: Pyrethroid Chemistry and Metabolism. In Handbook of Pesticide Toxicology Principles. Edited by Krieger R. London, San Diego: Academic Press; 2010.
• [18]Bomann W: Bayticol acid - Investigations of subacute toxicity in Wistar rats. Bayer Internal Study Report 1995, ID 24057, Submitted to WHO
• [19]Kraemer F, Krieger KJ, Schmuck G, Stanneck D: Seresto® - ein neues Polymermatrix-Halsband mit denWirkstoff en Flumethrin und Imidacloprid zum Langzeitschutz von Hunden und Katzen vor Zecken- und Flohbefall. Kleintier konkret, in press. http://dx.doi.org/10.1055/s-0031-1298092 webcite
• [20]Hopkins GEH, Rothschild M: An Illustrated Catalogue of the Rothschild Collection of Fleas (Siphonaptera) in the British Museum (Natural History) with Keys and Short Descriptions for the Identification of Families, Genera, Species and Subspecies. Vol. I. Tungidae and Pulicidae. London: Trustees of the British Museum; 1953.
• [21]Arther RG, Cunningham J, Dorn H, Everett R, Herr LG, Hopkins T: Efficacy of imidacloprid for removal and control of fleas (Ctenocephalides felis), on dogs. Am J Vet Res 1997, 58:848-850.
• [22]Arther RG, Bowman DD, McCall JW, Hansen O, Young DR: Feline Advantage Heart ™(Imidacloprid and Moxidectin) topical solution as monthly treatment for prevention of heartworm infection (Dirofilaria immitis) and control of fleas (Ctenocephalides felis) on cats. Parasitol Res 2003, 90:137-139.
• [23]Epe C, Coati N, Stanneck D: Efficacy of the compound preparation imidacloprid 10% (w/v)/Permethrin 50% (w/v) spot-on against ticks (I. ricinus, R. sanguineus) and fleas (C. felis) on dogs. Parasitol Res 2003, 90:123-124.
• [24]Hellmann K, Knoppe T, Krieger K, Stanneck D: European multicenter field trial on the efficacy and safety of a topical formulation of imidacloprid and permethrin (Advantix™) in dogs naturally infested with ticks and/or fleas. Parasitol Res 2003, 90:125-126.
• [25]Overgaauw P: Frontline Combo sucht die Schutzpraxis 2011. Kleintierpraxis 2011, 56:504.
• [26]Day MJ: One health: the importance of companion animal vector-borne diseases. Parasit Vectors 2011, 4:49. doi:10.1186/1756-3305-4-49 BioMed Central Full Text
• [27]Heile C, Hoffmann-Köhler P, Wiemann A, Schein E: Transmission time of tick-borne disease agents in dogs: Borrelia, Anaplasma, Ehrlichia and Babesia. Prakt Tierarzt 2007, 88:584-590.
• [28]Katavolos P, Armstrong PM, Dawson JE, et al.: Duration of tick attachment required for transmission of granulocytic ehrlichiosis. J Infect Dis 1998, 177:1422-1425.
• [29]Otranto D, Lia RP, Cantacessi C, Galli G, Paradies P, Mallia E, Capelli G: Efficacy of a combination of imidacloprid 10%/permethrin 50% versus fipronil 10%/(S)-methoprene 12%, against ticks in naturally infected dogs. Vet Par 2005, 130(3-4):293-304.
• [30]Lane RS, Burgdorfer W: Transovarial and Transstadial Passage of Borrelia burgdorferi in the Western Black-Legged Tick, Ixodes pacificus (Acari: Ixodidae). Am J Trop Med Hyg 1987, 37:188-192.